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Abstract The Tetrahymena group I ribozyme requires a
hierarchical folding process to form its correct three-dimensional
structure. Ribozyme activity depends on the catalytic core
consisting of two domains, P4^P6 and P3^P7, connected by a
triple-helical scaffold. The folding proceeds in the following
order: (i) fast folding of the P4^P6 domain, (ii) slow folding of
the P3^P7 domain, and (iii) structure rearrangement to form the
active ribozyme structure. The third step is believed to directly
determine the conformation of the active catalytic domain, but as
yet the precise mechanisms remain to be elucidated. To
investigate the folding kinetics of this step, we analyzed mutant
ribozymes having base substitution(s) in the triple-helical scaffold
and found that disruption of the scaffold at A105G results in
modest slowing of the P3^P7 folding (1.9-fold) and acceleration
of step (iii) by 5.9-fold. These results suggest that disruption or
destabilization of the scaffold is a normal component in the
formation process of the active structure of the wild type
ribozyme. ß 2001 Published by Elsevier Science B.V. on be-
half of the Federation of European Biochemical Societies.
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1. Introduction
The Tetrahymena group I ribozyme that has served as one
of the most useful model RNAs for investigation of the RNA
folding process forms a complex three-dimensional (3D) struc-
ture (Fig. 1A) [1^4]. This ribozyme conducts a self-splicing
reaction consisting of two conserved structural domains, P4^
P6 and P3^P7, which are connected covalently by two single
stranded regions, J3/4 and J6/7 [5,6]. The two domains are
packed together to form a conserved core that serves as an
active site to stabilize transitional states of chemical reactions
[5,7].
To correctly form its complex 3D structure, a hierarchical
procedure is followed by the Tetrahymena ribozyme (Fig. 1B)
[8]. A series of analyses by Zarrinkar and Williamson, and
Sclavi et al. determined the rate constants for the formation
of the two conserved domains, P4^P6 and P3^P7 (and other
regions), and established a basic framework for kinetic folding
of the two domains (Fig. 1B) [2,9,10]. In this process, the
intermediate secondary structure of the P4^P6 domain
(termed I1) forms rapidly, followed by formation of its terti-
ary structure (the next intermediate, I2). I2 is then converted
by the formation of two sets of base triples, J3/4UP6 and J6/
7UP4 to result in I3, which in turn conducts the folding of the
P3^P7 domain to form IF. The conversion from I2 to IF
mediated by I3 is distinctively slower than the P4^P6 forma-
tion. In the ¢nal step, conformational rearrangement of IF
occurs to form the catalytically active structure [2,10].
The overall rate of the folding pathway of the Tetrahymena
ribozyme (koverall) has been shown to depend on the concen-
tration of magnesium ions [11,12]. The rate is optimal at 2 mM
Mg2 and decreases gradually with an increase of magnesium
ion concentration although the overall framework of folding
hierarchy is maintained. Consequently, at 10 mM Mg2 which
is often used as the standard for assaying both the folding and
the reactions, koverall is approximately 20-fold slower than that
at 2 mM Mg2 [12]. Two slow steps are observed in this
folding (Fig. 1B): the ¢rst is the conversion from I2 to IF
mediated by I3 ; this step corresponds to the folding of the
P3^P7 domain. The second is the structural rearrangement
from IF to the active structure (20-fold slower than the ¢rst
step) [12,13]. It has been shown that the rate of P3^P7 folding
(kP3ÿP7) is only weakly in£uenced by magnesium ion concen-
trations ([12] and this study). The reduced koverall at 10 mM
Mg2 is mainly attributed to the reduced rate of the structural
rearrangement at the last step [12]. However, the mechanism
of this important structural rearrangement implicated in direct
determination of the active catalytic core conformation re-
mains poorly understood.
To analyze the structural elements in the catalytic core, we
have examined the activity of mutant group I ribozymes lack-
ing some of these elements. We found that ribozymes lacking
both base triples and the P4^P6 domain are still active, estab-
lishing that the P3^P7 domain constitutes the minimal cata-
lytic domain [14]. This result suggests that the base triples
enhance the folding and/or reaction of the ribozymes by im-
proving their correct folding and/or stabilizing the active
structure of the P3^P7 catalytic domain. We tested this hy-
pothesis by examining the structural rearrangement from IF to
the active structure of the Tetrahymena ribozyme.
2. Materials and methods
2.1. Preparation of RNAs
Plasmids encoding mutant ribozymes employed in this study were
prepared from the pTZIVSU plasmid [15] using polymerase chain
reaction (PCR)-dependent site-directed mutagenesis as described
[16], and the constructs veri¢ed by DNA sequencing. The template
DNAs for in vitro transcription of L-21 ScaI forms of the Tetrahy-
mena ribozyme and its mutants were generated by 20 cycles of PCR
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(94‡C, 30 s/55‡C, 2 s/74‡C, 1 min) using KOD DNA polymerase
(Toyobo, Japan). For PCR, 1 ng of template plasmid (an appropriate
derivative of pTZIVSU) and the following set of primers were used:
5P-TAA-TAC-GAC-TCA-CTA-TAG-GGC-GTC-AAA-TTG-CGG-
GAA-AGG-3P (the promoter sequence for T7 RNA polymerase is
underlined) and 5P-ACT-CCA-AAA-CTA-ATC-AAT-AT-3P. In vitro
transcription reactions with T7 RNA polymerase were performed as
described [17].
2.2. Gain of activity assay and kinetic oligonucleotide hybridization
assay
A gain of activity assay for measurement of koverall in the presence
of 10 mM Mg2 ions was performed as described by Zarrinkar and
Williamson [9]. The ¢nal concentrations of L-21 ScaI ribozyme and
substrate RNA whose 5P terminus was labeled with 32P (5P-CCCU-
CUAAAAA-3P) were 7 and 16 nM, respectively. Cleavage reactions
were performed for 30 s. Procedures for the gain of activity assay and
kinetic oligonucleotide hybridization assay at 2 mM Mg2 were iden-
tical to those at 10 mM Mg2 except that the ¢nal concentration of
magnesium ions in the folding bu¡er was reduced to 2 mM.
A kinetic oligonucleotide hybridization assay in the presence of 10
mM Mg2 ions was performed as described by Zarrinkar and Wil-
liamson [9,18]. To measure the folding kinetics of the P3^P7 domain,
a uniformly 32P-labeled L-21 ScaI ribozyme (1 nM) and an oligonu-
cleotide probe complementary to the P3 region (positions A270^G279,
20 WM) were used as described [9,19]. The kinetic oligonucleotide
hybridization assay at 2 mM Mg2 was identical to that at 10 mM
Mg2 except that the ¢nal concentration of magnesium ions in the
folding bu¡er was reduced to 2 mM.
All assays in this study were repeated three times. Experimental
errors represent the standard deviation from three independent experi-
ments.
3. Results and discussion
3.1. Design of mutants and experiments
The group I ribozyme possesses two sets of conserved base
triples, J3/4UP6 and J6/7UP4, at the interface between P4^P6
and P3^P7 domains (Fig. 1A) [5]. These two sets have been
considered to form consecutive base triples constituting a tri-
ple-helical sca¡old in the ribozyme tertiary structure [6]. J3/4
has been proposed to form base triples by interacting with
ribose-2P OH in the minor groove of P6 [20] whereas J6/7
was shown to form base triples by interactions with base
moieties in the major groove of P4 [21]. It is unclear whether
J3/4UP6 and/or J6/7UP4 plays any particular role in the
folding process.
To examine whether J3/4UP6 and J6/7UP4 act as a com-
bined unit or play independent roles in the folding process, we
compared the kinetic folding of two mutant ribozymes,
A105G and C260G, which have a base substitution in each
of the respective base triples. The A105G mutation is expected
to disrupt or destabilize base triples formed by J3/4 and P6 as
nuclear magnetic resonance studies of model RNA showed
that A105 forms base triples with the C216^G257 base pair
in P6 by using the N1 position of A105 and 2POH of G257
(Fig. 1A) [20]. The C260G mutant was prepared originally by
Zarrinkar and Williamson to disrupt or destabilize the J6/
7UP4 base triples (Fig. 1A) [10].
In the wild type Tetrahymena ribozyme, the structural re-
arrangement from IF to the active structure occurs rapidly at
2 mM Mg2. However, this rapid rearrangement poses di⁄-
culties for analysis of the rearrangement step because it is
kinetically indistinguishable from the preceding step (P3^P7
folding) [12]. To overcome this technical problem, we inves-
tigated the step at 10 mM Mg2 where the kinetic constant
can be distinguished without a¡ecting the overall framework
of the folding hierarchy (Fig. 1B).
3.2. Folding kinetics of a A105G mutant with a defect in
J3/4UP6 at 2 mM Mg2+
To study the folding kinetics and thermodynamic stability
of an A105G mutant with defective J3/4UP6 interaction, we
determined its folding rate in the presence of 2 mM Mg2, a
concentration that is optimum for the wild type Tetrahymena
ribozyme (Fig. 2A) [12]. By employing a gain of activity assay
that monitors the rate of active ribozyme formation as the
magnitude of the ¢rst turnover in an RNA cleavage reaction
[9], the rate (koverall) was measured by varying the folding
period in the presence of 2 mM Mg2 where derivatives of
the Tetrahymena ribozyme are often inactive (Fig. 2A) ([10]
and this study). The A105G mutant was found to be active
but its koverall (0.68 þ 0.04 min31) was 1.4-fold slower com-
pared to the wild type (0.94 þ 0.04 min31).
The rate of P3^P7 folding (kP3ÿP7) that corresponds to the
I2 to IF conversion rate was determined by employing a ki-
netic oligonucleotide hybridization assay that monitors fold-
ing of a speci¢c region in self-folding RNAs by using an
oligonucleotide complementary to the region [9,19]. The ex-
tent of RNA folding is estimated from the accessibility of the
oligonucleotide to the speci¢c region. By employing the assay,
P3^P7 can be de¢ned as folded when the P3 helix becomes
inaccessible to its complementary oligonucleotide (Fig. 2B)
[32]. At 2 mM Mg2, kP3ÿP7 of the A105G mutant
(0.77 þ 0.08 min31) was 1.9-fold slower compared with the
wild type (1.5 þ 0.1 min31). However, kP3ÿP7 of the mutant
at 2 mM Mg2 was similar to its koverall (0.68 þ 0.04 min31)
at 2 mM Mg2. This result suggested that the folding of the
P3^P7 domain is the rate limiting step in the formation of an
active A105G ribozyme at 2 mM Mg2 as this is consistent
with the situation in the wild type ribozyme at 2 mM Mg2
where koverall (0.94 þ 0.04 min31) is also close to kP3ÿP7
(1.5 þ 0.01 min31) (Fig. 2A,B) [12].
Table 1
Folding rate [Mg2] (mM) Wild type A105G C260G A105G/C260G
koverall 2 0.94 (1.1b) 0.68 ^a ^a
kP3ÿP7 2 1.5 (1.2b) 0.77 ^a ^a
koverall 10 0.07 (0.06b) 0.41 0.06 0.15
kP3ÿP7 10 1.6 (1.2b;c, 0.72d) 0.84 (0.15d) 0.32
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3.3. Folding kinetics of A105G mutant at 10 mM Mg2+
In the presence of 10 mM Mg2, the rate of folding of the
wild type ribozyme is slowed presumably because the inter-
mediate form(s) is stabilized by Mg2 ions [11,12]. At 10 mM
Mg2, the rate limiting step of the kinetics is the conforma-
tional change from P3^P7 folding to the active ribozyme (Fig.
1B): the formation of the active ribozyme (koverall) is approx-
imately 20-fold slower than that of the P3^P7 domain (kP3ÿP7)
[12].
We compared the folding kinetics of the A105G mutant
with the wild type ribozyme at 10 mM Mg2 and found
that the active mutant ribozyme is formed 5.9-fold
(0.41 þ 0.02 min31) faster than the active wild type
(0.07 þ 0.00 min31) (Fig. 2A). The e⁄ciency of the mutant
ribozyme in cleaving the substrate RNA was maximized
(0.61 nM/30 s) after 20 min folding at 10 mM Mg2 (Fig.
2A). The maximal e⁄ciency of the mutant ribozyme in cleav-
ing substrate RNA (0.61 nM/30 s) was nearly identical to that
of the wild type folded at 2 mM Mg2 (0.63 nM/30 s), sug-
gesting that most of the population of A105G ribozyme
folded into the fully active form within 20 min. The result is
quite di¡erent from that of the wild type folded at 10 mM
Mg2 where only 80% of the ribozyme population is active
even after 120 min folding [12].
The koverall of the mutant was only modestly in£uenced by
Fig. 2. Folding kinetics of A105G mutant ribozyme. A: Kinetics of
active structure formation for the wild type and the A105G mutant
at 37‡C in the presence of 10 or 2 mM Mg2. Observed rates were
0.07 þ 0.00 min31 for the wild type at 10 mM Mg2 (¢lled square),
0.41 þ 0.02 min31 for A105G at 10 mM Mg2 (¢lled circle),
0.94 þ 0.04 min31 for the wild type at 2 mM Mg2 (open square),
and 0.68 þ 0.04 min31 for A105G at 2 mM Mg2 (open circle). B:
Kinetics of P3 helix formation in the wild type and the A105G mu-
tant at 37‡C in the presence of 10 or 2 mM Mg2. Observed rates
were 1.6 þ 0.1 min31 for the wild type at 10 mM Mg2 (¢lled
square), 0.84 þ 0.08 min31 for A105G at 10 mM Mg2 (¢lled circle),
1.5 þ 0.1 min31 for the wild type at 2 mM Mg2 (open square), and
0.77 þ 0.08 min31 for A105G at 2 mM Mg2 (open circle).
Fig. 1. Structure and folding pathway of the Tetrahymena ribozyme.
A: The secondary structure of the L-21 Tetrahymena ribozyme. The
secondary structure of the Tetrahymena intron ribozyme is redrawn
from [6,31]. Arrowheads superimposed on lines indicate 5P-to-3P po-
larity. The P3 sequence targeted by a complementary oligonucleo-
tide probe for kinetic oligonucleotide hybridization assay is indi-
cated with a bold line [9]. The substrate RNA for gain of activity
assay is indicated as outline. Mutations analyzed in this study are
indicated by white arrows; J3/4 mutant: A105G, J6/7 mutant:
C260G, double mutant: A105G/C260G. Positions A183 (A-rich
bulge) and U273 (P3 region) that are discussed in the text are also
indicated. B: Simpli¢ed scheme of the folding pathway of the core
region of the L-21 Tetrahymena ribozyme. I1 and I2 represent the
folding intermediates in which the P4^P6 domain forms secondary
and tertiary structures, respectively [9]. I3 represents the intermediate
in which the P4^P6 domain and four consecutive base triples are
formed [10]. IF represents the intermediate in which both P4^P6
and P3^P7 domains are folded [4,10].
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the concentration of magnesium ions (1.7-fold reduction by
increasing Mg2 ions from 2 to 10 mM, Fig. 2A, Table 1) in
contrast with the more drastic e¡ect on the koverall of the wild
type (13-fold (this study) or 18-fold [12] reduction by increas-
ing Mg2 ion concentration from 2 to 10 mM, Fig. 2A, Table
1).
The rates of P3^P7 folding for the wild type and A105G
mutant were also determined by the kinetic oligonucleotide
hybridization assay technique (Fig. 2B). The kP3ÿP7 of the
mutant was found to be 0.77 þ 0.08 or 0.84 þ 0.08 min31 at
2 or 10 mM Mg2, respectively, whereas that of the wild type
was 1.5 þ 0.1 or 1.6 þ 0.1 min31 at 2 or 10 mM Mg2, respec-
tively (Table 1). The rates for the mutant were therefore 1.9-
fold slower than those for the wild type. However, the folding
of the P3^P7 domain of both the mutant and the wild type
was, similarly, essentially independent from the Mg2 concen-
tration (Fig. 2B, [12]).
3.4. Comparison with other fast-folding mutants
The single base substitutions at positions A183 (A-rich
bulge) and U273 (P3 region) in two variant ribozymes,
A183U and U273A, respectively, have been known to accel-
erate formation of the active structures (Fig. 1B) [13,22]. In
the presence of 10 mM Mg2, the P3^P7 folding in A183U is
accelerated about ¢ve-fold and the formation of the active
structure about 1.6-fold (compared with the wild type)
[13,23]. Formation of the active structure of A183U, however,
is distinctly slower than that of the A105G mutant which
folds 5.5-fold faster than the wild type with no reduction in
ribozyme activity (Fig. 2A). In the case of a U273A mutant,
the rate of P3^P7 folding equals that of the P4^P6 folding,
and its active structure is formed at least 10^15-fold faster
than the wild type at 4 mM Mg2 [23,24]. Although no mis-
folding occurs, this mutation results in reduction of the cata-
lytic activity by about two-fold (compared with the wild type)
presumably because the mutation alters Mg2 coordination,
docking of P1 substrate helix and/or binding of a guanosine
cofactor [23]. In contrast, A105G mutant is as active as the
wild type under optimal conditions (2 mM Mg2) (Fig. 2A).
The A183U and U273A mutants thus accelerate the forma-
tion of the active structure by increasing the rate of the P3^P7
domain folding. In the A105G mutant, a modest decrease in
the P3^P7 folding accelerates the formation of the active
structure, suggesting that J3/4UP6 base triples play a speci¢c
role in the ¢nal folding step of the ribozyme (Fig. 2A,B).
3.5. Folding kinetics of mutants with a defect at J6/7UP4
We determined koverall at 10 mM Mg2 for a C260G mutant
with a defect at J6/7UP4 to be 0.06 þ 0.00 min31. This is 6.8-
fold less than that for the A105G mutant (0.41 min31) in
which J3/4UP6 is disrupted, but the koverall remains virtually
identical to that for the wild type (Fig. 3A). This implies that
the rate of formation of the active ribozyme is identical for
both the mutant and wild type ribozymes. (Note: we inde-
pendently re-determined the value of koverall for the C260G
mutant because the koverall for the wild type ribozyme was
corrected recently from 0.61 min31 [9] to 0.06 min31 [12])
To examine the e¡ects of double mutations at positions
A105 and C260, koverall at 10 mM Mg2 was determined for
A105G/C260G mutant containing disruptions in both J3/
4UP6 and J6/7UP4. The value for this mutant (0.15 þ 0.01
min31) was 2.3-fold higher than that of the wild type or
C260G mutant although it is 2.7-fold less than that of the
A105G mutant (compare Fig. 3A to Fig. 2A), suggesting
that the A105G mutation is able to accelerate the formation
of active ribozyme even in the presence of the disrupted J6/
7UP4.
In a gain of activity assay, the reaction product was ob-
served at the zero time point of the wild type or A105G
ribozyme at 10 mM Mg2 as shown in Fig. 2A. The burst
represents the fraction of the ribozyme that folds within 30 s
as described by Rook et al. [13]. This suggests the existence of
a fast-folding pathway without kinetic traps which has re-
cently been indicated by a single molecular analysis of the
Tetrahymena ribozyme [22,25^27]. However, no fast-folding
Fig. 3. Folding kinetics of C260G and A105G/C260G mutant. A:
Kinetics of active structure formation for the C260G and the
A105G/C260G mutants at 37‡C in the presence of 10 mM Mg2.
Observed rates were 0.06 þ 0.00 min31 for C260G (¢lled diamond),
and 0.15 þ 0.01 min31 for A105G/C260G double mutant (¢lled tri-
angle). B: Kinetics of P3 helix formation in the A105G/C260G dou-
ble mutant at 37‡C in the presence of 10 mM Mg2. Observed rate
was 0.32 þ 0.03 min31.
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fraction was detected for the C260G mutant (Fig. 3A).
Although the nature of the fast-folding pathway is unclear,
our results suggest that formation of J6/7UP4 base triples is
essential for this folding pathway whereas J3/4UP6 base tri-
ples appear not to be involved as the fast-folding fraction is
still observed in the A105G mutant (Fig. 2A).
The rate of P3^P7 folding was determined for the A105G/
C260G double mutant (Fig. 3B). In the presence of 2 mM
Mg2, the P3 region was cleaved completely by RNase H
depending on the oligonucleotide complementary to P3
(data not shown), indicating the inability of the P3^P7 region
to fold stably at 2 mM Mg2. The result is consistent with the
observations that the double mutant is catalytically inactive
(data not shown) and P3^P7 of the C260G mutant does not
fold stably in the presence of 2 mM Mg2 [10].
At 10 mM Mg2, the P3^P7 domain of the double mutant
folds stably and its rate of kinetic folding is 0.32 þ 0.03 min31
which is 5- or 2.6-fold lower than that of the wild type or
A105G mutant, respectively (Fig. 3B). The P3^P7 domain of
the C260G mutant is known to fold ¢ve-fold slower than the
wild type ribozyme [10], indicating that the reduced P3^P7
folding rate for the double mutant is mainly due to the
C260G mutation.
3.6. The base triples in kinetic folding
Analysis of the kinetic folding of a C260G mutant (with a
defect at J6/7UP4 triples) at 10 mM Mg2 by Zarrinkar and
Williamson has shown that the C260G mutation slows for-
mation of the P3^P7 domain by 4.8-fold compared with the
wild type (Table 1, [10]), suggesting that formation of the
triple-helical sca¡old leads the folding of the P3^P7 domain
[10]. In the present study, we show that a A105G mutation
(disrupting J3/4UP6) also modestly slows the P3^P7 folding
(1.9-fold). The fact that both A105G and C260G mutations
cause inhibitive e¡ects on P3^P7 folding suggests that both J3/
4UP6 and J6/7UP4 triples are involved in guiding the folding
of P3^P7 domain. At this step, J6/7UP4 triples seem to play a
major role because the C260G mutation more severely retards
P3^P7 folding (4.8-fold) than the A105G mutation (1.9-fold).
The rearrangement from IF to the active ribozyme is the
slowest step in the kinetic folding of the wild type ribozyme at
10 mM Mg2 (Figs. 1 and 2). A mutation at A105G acceler-
ates this step by 5.9-fold (Fig. 2A, Table 1) but the C260G
mutation has no e¡ect on this step (Fig. 3A, Table 1). This
result indicates that the A105G mutation a¡ects at least two
steps in the kinetic folding: it slows folding of the P3^P7
domain but accelerates the formation of active ribozyme.
The acceleration in the formation of active ribozyme sug-
gests that disruption or destabilization of J3/4UP6 triples sig-
ni¢cantly contributes to the fast rearrangement from IF to the
active ribozyme. This e¡ect is likely to be totally or mostly
independent from that of the J6/7UP4 triples because forma-
tion of the active structure of the A105G/C260G mutant oc-
curs 2.1-fold faster than in the wild type while the C260G
single mutation has no e¡ect on this step (Fig. 3). These
results indicate that the two base triples, J3/4UP6 and J6/
7UP4, play distinct roles in the folding mechanism. J6/
7UP4 mainly contributes to the induction of P3^P7 folding
and J3/4UP6 to regulation of the rearrangement from IF to
the active ribozyme.
Recent analyses have indicated that transient tertiary inter-
actions are required for structural rearrangement in the self-
splicing of group I and II intron RNAs [28^30]. We have
shown that the disruption of one set of base triples, J3/
4UP6, connecting the two core domains, P4^P6 and P3^P7,
enhances structural rearrangement for formation of the active
structure of the Tetrahymena group I ribozyme in the presence
of 10 mM Mg2. This prompted us to propose the following
hypothesis. At lower concentrations of Mg2, the base triples
are unstable so that fast and smooth rearrangement from IF
to the active structure is allowed to proceed without hindrance
[11,12]. However, at higher concentrations of Mg2, they be-
come more in£exible and this critical conformational rear-
rangement becomes the rate limiting step for building the
active structure [11,12]. This hypothesis might explain why
an A105G mutation that possibly relaxes the base triples is
highly e¡ective for rapid formation of the active structure in
the presence of 10 mM Mg2. It also suggests that conforma-
tional rearrangement of the base triples in the wild type ribo-
zyme might occur in the formation of the active structure
under physiological conditions.
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